Sargramostim
Top View
- White Blood Cell Colony Stimulating Factors – Value & Balance Exchange Medical Benefit Drug Policy
- Production Design of Efficient Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Under a Gene-Specific Promoter in Prokaryotic System
- Effects of GM-CSF on Dendritic Cells and Regulatory T Cells in Parkinson’S Disease Patients and Models of Parkinson’S Disease
- The Impact of Biosimilar Competition June 2016 the Impact of Biosimilar Competition Introduction
- Treatment of Metastatic Uveal Melanoma: Systematic Review
- White Blood Cell Growth Factors
- Colony Stimulating Factors - Leukine® (Sargramostim Injection)
- How I Treat Patients Who Mobilize Hematopoietic Stem Cells Poorly
- The Impact of Biosimilar Competition in Europe Contents
- Ipilimumab Plus Sargramostim Vs Ipilimumab Alone
- A Phase I Study of Recombinant Human Leukemia Inhibitory Factor in Patients with Advanced Cancer1
- TCR Template
- Synthesis of Granulocyte–Macrophage Colony- Stimulating Factor As Homogeneous Glycoforms and Early Comparisons with Yeast Cell-Derived Material
- Colony Stimulating Factors
- HEMATOPOIETIC AGENTS;GROWTH FACTORS,MINERALS and VITAMINS Phr.Volkan KAHRAMAN HGF’S
- Pegfilgrastim), Leukine® (Sargramostim), Granix (Tbo-Filgrastim
- Sargramostim
- United States Patent (19) 11 Patent Number: 5,670477 Poduslo Et Al